ClinicoEconomics and Outcomes Research
译名:临床经济学与结果研究
1-3
2026
影响因子区间
—
平台估算
4%
2025
中国作者发文占比
40000000 IRR;600 USD
收费
期刊简介:ClinicoEconomics and Outcomes Research is an international, peer-reviewed open-access journal focusing on Health Technology Assessment, Pharmacoeconomics and Outcomes Research in the areas of diagnosis, medical devices, and clinical, surgical and pharmacological intervention. The economic impact of health policy and health systems organization also constitute important areas of coverage. The aim of the journal is to rapidly and concisely publish outcomes studies, methodologies, reviews, and reports across all disease areas. In addition, evaluations investigating prescribing behavior, practice guidelines, cost-of-illness, cost of treatment, and cost-effectiveness will be welcome. The journal will also specifically explore patient reported outcomes, satisfaction, preference and adherence, willingness-to-pay (WTP), cost-utility, cost-benefit, disease management strategies, and drug health & policy. Papers reporting on the effective deployment of diagnostic, screening, clinical and surgical interventions, and the use of medicines and devices to maximize healthcare resources for the benefit of the patient will be given particular priority. ClinicoEconomics and Outcomes Research will no longer consider meta-analyses for publication.
【译文】《ClinicoEconomics and Outcomes Research》是一本经过同行评审的国际开放获取期刊,专注于诊断、医疗器械以及临床、外科和药理学干预领域的健康技术评估、药物经济学和结果研究。卫生政策和卫生系统组织的经济影响也是重要的覆盖领域。该杂志的目标是快速、简洁地发表所有疾病领域的结果研究、方法、评论和报告。此外,欢迎对处方行为、实践指南、疾病成本、治疗成本和成本效益进行评估。该杂志还将专门探讨患者报告的结果、满意度、偏好和依从性、支付意愿(WTP)、成本效用、成本效益、疾病管理策略以及药物健康和政策。报告有效部署诊断、筛查、临床和外科干预措施以及使用药物和设备最大限度地利用医疗资源造福患者的论文将受到特别优先考虑。临床经济学和结果研究将不再考虑发表荟萃分析。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |